Unknown

Dataset Information

0

Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1.


ABSTRACT: PHT1 is a histidine /oligopeptide transporter with an essential role in Toll-like receptor innate immune responses. It can act as a receptor by recruiting the adaptor protein TASL which leads to type I interferon production via IRF5. Persistent stimulation of this signalling pathway is known to be involved in the pathogenesis of systemic lupus erythematosus (SLE). Understanding how PHT1 recruits TASL at the molecular level, is therefore clinically important for the development of therapeutics against SLE and other autoimmune diseases. Here we present the Cryo-EM structure of PHT1 stabilized in the outward-open conformation. By combining biochemical and structural modeling techniques we propose a model of the PHT1-TASL complex, in which the first 16 N-terminal TASL residues fold into a helical structure that bind in the central cavity of the inward-open conformation of PHT1. This work provides critical insights into the molecular basis of PHT1/TASL mediated type I interferon production.

SUBMITTER: Custodio TF 

PROVIDER: S-EPMC10502012 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1.

Custódio Tânia F TF   Killer Maxime M   Yu Dingquan D   Puente Virginia V   Teufel Daniel P DP   Pautsch Alexander A   Schnapp Gisela G   Grundl Marc M   Kosinski Jan J   Löw Christian C  

Nature communications 20230914 1


PHT1 is a histidine /oligopeptide transporter with an essential role in Toll-like receptor innate immune responses. It can act as a receptor by recruiting the adaptor protein TASL which leads to type I interferon production via IRF5. Persistent stimulation of this signalling pathway is known to be involved in the pathogenesis of systemic lupus erythematosus (SLE). Understanding how PHT1 recruits TASL at the molecular level, is therefore clinically important for the development of therapeutics ag  ...[more]

Similar Datasets

| S-EPMC10589346 | biostudies-literature
| S-EPMC1221811 | biostudies-other
| S-EPMC10073072 | biostudies-literature
| S-EPMC5938892 | biostudies-literature
| S-EPMC5826766 | biostudies-literature
| S-EPMC9016627 | biostudies-literature
| S-EPMC6823300 | biostudies-literature
| S-EPMC6778262 | biostudies-literature
| S-EPMC6971037 | biostudies-literature
2021-06-12 | GSE177036 | GEO